PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 37 filers reported holding PLX PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $847,000 | -81.4% | 1,303,800 | -30.5% | 0.07% | -75.8% |
| Q2 2022 | $4,556,000 | -39.9% | 1,875,000 | 0.0% | 0.28% | -31.5% |
| Q1 2022 | $7,575,000 | -83.2% | 1,875,000 | -66.7% | 0.41% | -17.0% |
| Q4 2021 | $45,057,000 | +24.5% | 5,625,000 | +200.0% | 0.49% | -55.0% |
| Q3 2021 | $36,188,000 | +39.9% | 1,875,000 | 0.0% | 1.10% | +62.3% |
| Q2 2021 | $25,875,000 | +52.8% | 1,875,000 | 0.0% | 0.68% | +5.3% |
| Q1 2021 | $16,931,000 | – | 1,875,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |